Heartseed Inc. (TYO:219A)

Revenue by Segment

Financials in millions JPY. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023
Pharmaceutical Business	3.03B	873.61M	344.73M
Pharmaceutical Business Growth	246.44%	153.42%	-
Total	3.03B	873.61M	344.73M
Total Growth	246.44%	153.42%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 6, 2026

Data Sources Report a data error